These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22968971)

  • 1. Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients.
    Schroeder HW; Dougherty CJ
    Infection; 2012 Dec; 40(6):601-11. PubMed ID: 22968971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of intravenous immunoglobulin G (IVIG).
    Looney RJ; Huggins J
    Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating dose ratio of subcutaneous to intravenous immunoglobulin therapy among patients with primary immunodeficiency disease switching to 20% subcutaneous immunoglobulin therapy.
    Krishnarajah G; Lehmann JK; Ellman B; Bhak RH; DerSarkissian M; Leader D; Bullinger AL; Sheng Duh M
    Am J Manag Care; 2016 Oct; 22(15 Suppl):s475-s481. PubMed ID: 27849353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new intravenous immunoglobulin (BIVIGAM®) for primary humoral immunodeficiency.
    Wasserman RL
    Expert Rev Clin Immunol; 2014 Mar; 10(3):325-37. PubMed ID: 24527947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
    Pac M
    Pol Merkur Lekarski; 2011 Jun; 30(180):413-6. PubMed ID: 21751550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I.V. immunoglobulin therapy for infectious diseases.
    Drug Ther Bull; 2010 May; 48(5):57-60. PubMed ID: 20447982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin treatment of immunodeficiency disorders.
    Schwartz SA
    Pediatr Clin North Am; 2000 Dec; 47(6):1355-69. PubMed ID: 11131000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with Flebogamma 5% DIF: a new generation of intravenous immunoglobulins in patients with primary immunodeficiency disease.
    Ballow M
    Clin Exp Immunol; 2009 Sep; 157 Suppl 1(Suppl 1):22-5. PubMed ID: 19630866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should therapeutic immunoglobulin be considered a generic product? An evidence-based approach.
    Misbah SA
    J Allergy Clin Immunol Pract; 2013; 1(6):567-72. PubMed ID: 24565702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy.
    Kaveri SV; Maddur MS; Hegde P; Lacroix-Desmazes S; Bayry J
    Clin Exp Immunol; 2011 Jun; 164 Suppl 2(Suppl 2):2-5. PubMed ID: 21466545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the use of immunoglobulin in human disease: A review of evidence.
    Perez EE; Orange JS; Bonilla F; Chinen J; Chinn IK; Dorsey M; El-Gamal Y; Harville TO; Hossny E; Mazer B; Nelson R; Secord E; Jordan SC; Stiehm ER; Vo AA; Ballow M
    J Allergy Clin Immunol; 2017 Mar; 139(3S):S1-S46. PubMed ID: 28041678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin in immunodeficiency states: state of the art.
    Toubi E; Etzioni A
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):167-72. PubMed ID: 16391391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
    Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
    Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nursing guidelines for administration of immunoglobulin replacement therapy.
    Younger ME; Aro L; Blouin W; Duff C; Epland KB; Murphy E; Sedlak D;
    J Infus Nurs; 2013; 36(1):58-68. PubMed ID: 23271153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of immune globulin intravenous for treatment of immune deficient patients--United States, 1997-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Mar; 48(8):159-62. PubMed ID: 10079062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral sinus thrombosis in a patient with humoral immunodeficiency on intravenous immunoglobulin therapy: a case report.
    Barada W; Muwakkit S; Hourani R; Bitar M; Mikati M
    Neuropediatrics; 2008 Apr; 39(2):131-3. PubMed ID: 18671192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.
    Wasserman RL; Lumry W; Harris J; Levy R; Stein M; Forbes L; Cunningham-Rundles C; Melamed I; Kobayashi AL; Du W; Kobayashi R
    J Clin Immunol; 2016 Aug; 36(6):590-9. PubMed ID: 27324887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin Replacement Therapy for Primary Immunodeficiency.
    Sriaroon P; Ballow M
    Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases.
    Ballow M; Pinciaro PJ; Craig T; Kleiner G; Moy J; Ochs HD; Sleasman J; Smits W
    J Clin Immunol; 2016 Aug; 36(6):583-9. PubMed ID: 27279130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies].
    Lewandowicz-Uszyńska A; Jankowski A
    Pol Merkur Lekarski; 2011 Jun; 30(180):409-12. PubMed ID: 21751549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.